Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with a restricted-access notice; the visible area shows a simple header and footer with the error message.
    Difference
    20%
    Check dated 2026-09-21T19:53:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    A new page revision tag, v3.6.6, has been added and the previous tag, v3.6.5, removed. This reflects a minor update to the page’s versioning or formatting.
    Difference
    0.1%
    Check dated 2026-08-31T16:46:22.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page adds footer-level metadata and regulatory context, including FDA-regulated notices, IPD planning, PubMed publications, and related topic links, enhancing access to regulatory information and related resources without altering the study details.
    Difference
    56%
    Check dated 2026-08-17T12:21:01.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.5, indicating a minor update to the study record's metadata.
    Difference
    0.1%
    Check dated 2026-08-10T07:39:04.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4. This appears to be a minor template or platform update with no changes to the study details or user interactions.
    Difference
    0.1%
    Check dated 2026-07-26T19:20:40.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page revision updates to version v3.6.3, signaling a small update to the study record. There are no visible changes to the study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-05T04:34:47.000Z thumbnail image

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.